{"DataElement":{"publicId":"7449170","version":"1","preferredName":"Gallbladder Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for gallbladder carcinoma, using AJCC Ed. 8 criteria.","longName":"GBC_AJC8_DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7449155","version":"1","preferredName":"Gallbladder Neoplasm Stage Grouping","preferredDefinition":"A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"2452440v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452440","version":"1","preferredName":"Gallbladder Neoplasm","preferredDefinition":"A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12377:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder","conceptCode":"C12377","definition":"A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6541-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B0783168-C836-727C-E053-4EBD850A354E","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-12-14","changeDescription":"2020-12-14 TL released. TL created for standardization; requested by ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7449091","version":"1","preferredName":"Gallbladder Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7449091v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Stage IVB Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449093","version":"1","preferredName":"Stage IVB Gallbladder Cancer AJCC v8","longName":"7449093","preferredDefinition":"Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1). N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Gallbladder Cancer AJCC v8","conceptCode":"C134678","definition":"Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1). N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BE02-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BE1B-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449095","version":"1","preferredName":"Stage IVA Gallbladder Cancer AJCC v8","longName":"7449095","preferredDefinition":"Stage IVA includes: T4, N0-1, M0. T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Gallbladder Cancer AJCC v8","conceptCode":"C134676","definition":"Stage IVA includes: T4, N0-1, M0. T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BE28-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BE41-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449097","version":"1","preferredName":"Stage IV Gallbladder Cancer AJCC v8","longName":"7449097","preferredDefinition":"Stage IV includes: IVA: T4, N0-1, M0; IVB: (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Gallbladder Cancer AJCC v8","conceptCode":"C134675","definition":"Stage IV includes: IVA: T4, N0-1, M0; IVB: (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BE4E-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BE67-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449099","version":"1","preferredName":"Stage IIIB Gallbladder Cancer AJCC v8","longName":"7449099","preferredDefinition":"Stage IIIB includes: T1-3, N1, M0. T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Gallbladder Cancer AJCC v8","conceptCode":"C134674","definition":"Stage IIIB includes: T1-3, N1, M0. T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BE74-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BE8D-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449101","version":"1","preferredName":"Stage IIIA Gallbladder Cancer AJCC v8","longName":"7449101","preferredDefinition":"Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Gallbladder Cancer AJCC v8","conceptCode":"C134673","definition":"Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BE9A-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BEB3-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449103","version":"1","preferredName":"Stage III Gallbladder Cancer AJCC v8","longName":"7449103","preferredDefinition":"Stage III includes: IIIA: (T3, N0, M0); IIIB: (T1-3, N1, M0). T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Gallbladder Cancer AJCC v8","conceptCode":"C134672","definition":"Stage III includes: IIIA: (T3, N0, M0); IIIB: (T1-3, N1, M0). T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BEC0-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BED9-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449105","version":"1","preferredName":"Stage IIB Gallbladder Cancer AJCC v8","longName":"7449105","preferredDefinition":"Stage IIB includes: T2b, N0, M0. T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Gallbladder Cancer AJCC v8","conceptCode":"C134671","definition":"Stage IIB includes: T2b, N0, M0. T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BEE6-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BEFF-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449107","version":"1","preferredName":"Stage IIA Gallbladder Cancer AJCC v8","longName":"7449107","preferredDefinition":"Stage IIA includes: T2a, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Gallbladder Cancer AJCC v8","conceptCode":"C134670","definition":"Stage IIA includes: T2a, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BF0C-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BF25-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449109","version":"1","preferredName":"Stage II Gallbladder Cancer AJCC v8","longName":"7449109","preferredDefinition":"Stage II includes: IIA: T2a, N0, M0; IIB: T2b, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Gallbladder Cancer AJCC v8","conceptCode":"C134667","definition":"Stage II includes: IIA: T2a, N0, M0; IIB: T2b, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BF32-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BF4B-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449111","version":"1","preferredName":"Stage I Gallbladder Cancer AJCC v8","longName":"7449111","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or muscular layer. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Gallbladder Cancer AJCC v8","conceptCode":"C134665","definition":"Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or muscular layer. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BF58-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BF71-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Gallbladder Cancer AJCC v8","ValueMeaning":{"publicId":"7449113","version":"1","preferredName":"Stage 0 Gallbladder Cancer AJCC v8","longName":"7449113","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Gallbladder Cancer AJCC v8","conceptCode":"C134663","definition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BF7E-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B07810BB-BF97-7431-E053-4EBD850A274F","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7449090","version":"1","preferredName":"Gallbladder Cancer by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.):An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C134660:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Cancer by AJCC v8 Stage","conceptCode":"C134660","definition":"A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B07810BB-BDD5-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"ONEDATA","dateModified":"2020-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B07810BB-BDE6-7431-E053-4EBD850A274F","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-09-30","changeDescription":"TL created for standardization; requested by ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"7448902","version":"1","longName":"Gallbladder","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B078485E-3101-7339-E053-4EBD850AFA4E","latestVersionIndicator":"Yes","beginDate":"2020-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-29","modifiedBy":"TAYLORT","dateModified":"2020-12-14","changeDescription":"2020-12-14 TL released. TL created for standardization; requested by ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}